<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39399129</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-7076</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>IJID regions</Title><ISOAbbreviation>IJID Reg</ISOAbbreviation></Journal><ArticleTitle>Detection of COVID-19 incidence among attendees of the 2022 Hajj season.</ArticleTitle><Pagination><StartPage>100439</StartPage><MedlinePgn>100439</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100439</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijregi.2024.100439</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study investigated the presence of COVID-19 cases among pilgrims, health care workers (HCWs), and non-HCWs of Hajj 2022.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Nasopharyngeal samples were collected from 491 attendees of Hajj 2022. All participants received three doses of COVID-19 vaccines. Paired (n = 138; 69 participants) and unpaired (n = 422; 422 participants) nasopharyngeal swabs were subjected to reverse transcription-polymerase chain reaction targeting E gene of β-coronaviruses and RNA-dependent RNA polymerase of SARS-CoV-2. The results were linked to the participants' profiles, including role during Hajj, presence of respiratory symptoms or comorbidities, contact with symptomatic individuals, smoking status, and COVID-19 recovery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 20 (20 of 560; 3.6%) samples tested positive for COVID-19. Most cases (18 of 20; 90%) were pilgrims and non-HCWs. Six (30%) samples belonged to participants with previous positive reverse transcription-polymerase chain reaction. A total of 12 (60%) samples belonged to participants with respiratory symptoms. Three (15%) cases were linked to participants who had contact with individuals with respiratory symptoms. All cases belonged to individuals with no comorbidities, apart from a single case who has a chronic sinusitis. Five (25%) cases were smokers. No significant association was found between positive COVID-19 test and participants' profiles.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Few COVID-19 cases were detected in this study. Sustainable surveillance of COVID-19 and other respiratory viruses during Hajj seasons remains necessary.</AbstractText><CopyrightInformation>© 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alandijany</LastName><ForeName>Thamir A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qashqari</LastName><ForeName>Fadi S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Microbiology, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfelali</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hariri</LastName><ForeName>Sumyya H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Microbiology, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faizo</LastName><ForeName>Arwa A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khairo</LastName><ForeName>Yusuf M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qashqari</LastName><ForeName>Hanin A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahareth</LastName><ForeName>Elaf M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajodah</LastName><ForeName>Abdullah A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saeedi</LastName><ForeName>Abdullah F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garout</LastName><ForeName>Raed M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Kafrawy</LastName><ForeName>Sherif A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azhar</LastName><ForeName>Esam I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>IJID Reg</MedlineTA><NlmUniqueID>9918418183106676</NlmUniqueID><ISSNLinking>2772-7076</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hajj</Keyword><Keyword MajorTopicYN="N">Mass gathering</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Saudi Arabia</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399129</ArticleId><ArticleId IdType="pmc">PMC11470398</ArticleId><ArticleId IdType="doi">10.1016/j.ijregi.2024.100439</ArticleId><ArticleId IdType="pii">S2772-7076(24)00110-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alandijany TA. Respiratory viral infections during Hajj seasons. J Infect Public Health. 2024;17:42–48. doi: 10.1016/j.jiph.2023.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.04.006</ArticleId><ArticleId IdType="pubmed">37085376</ArticleId></ArticleIdList></Reference><Reference><Citation>Memish ZA, Alshamrani MM, Kattan RF, Azhar EI, Farahat FM, Albarrak AM, et al. Reducing risks from respiratory pathogens at the 2024 Hajj. Lancet Infect Dis. 2024;24:573–575. doi: 10.1016/S1473-3099(24)00260-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00260-3</ArticleId><ArticleId IdType="pubmed">38670130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumla A, Traore T, Amao L, Ntoumi F, Sharma A, Azhar EI, et al. Reducing the threat of epidemic-prone infections at mass gathering religious events. Lancet. 2022;400:80–82. doi: 10.1016/S0140-6736(22)01194-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01194-1</ArticleId><ArticleId IdType="pubmed">35772412</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris S, Hao S, Bose S, England ACI, Ivanov A, Mukherjee UK, et al. Detecting and mitigating simultaneous waves of COVID-19 infections. Sci Rep. 2022;12:16727. doi: 10.1038/s41598-022-20224-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-20224-5</ArticleId><ArticleId IdType="pmc">PMC9537162</ArticleId><ArticleId IdType="pubmed">36202867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha ICN, Pelayo MGA, Rackimuthu S. Kumbh mela religious gathering as a massive superspreading event: potential culprit for the exponential surge of COVID-19 cases in India. Am J Trop Med Hyg. 2021;105:868–871. doi: 10.4269/ajtmh.21-0601.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.21-0601</ArticleId><ArticleId IdType="pmc">PMC8592171</ArticleId><ArticleId IdType="pubmed">34460415</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla S, Khan R, Ahmed Y, Memish ZA. Conducting mass gathering events during the COVID-19 pandemic: a case study of Kumbh Mela 2021 as a potential 'super spreader event. J Travel Med. 2021;28 doi: 10.1093/jtm/taab160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taab160</ArticleId><ArticleId IdType="pmc">PMC8500053</ArticleId><ArticleId IdType="pubmed">34609481</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsayed SM, Alandijany TA, El-Kafrawy SA, Hassan AM, Bajrai LH, Faizo AA, et al. Pattern of respiratory viruses among pilgrims during 2019 Hajj season who sought healthcare due to severe respiratory symptoms. Pathogens. 2021;10:315. doi: 10.3390/pathogens10030315.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10030315</ArticleId><ArticleId IdType="pmc">PMC8001913</ArticleId><ArticleId IdType="pubmed">33800223</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Kafrawy SA, Alsayed SM, Faizo AA, Bajrai LH, Uthman NA, Alsaeed MS, et al. Genetic diversity and molecular analysis of human influenza virus among pilgrims during Hajj. Heliyon. 2024;10:e23027. doi: 10.1016/j.heliyon.2023.e23027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e23027</ArticleId><ArticleId IdType="pmc">PMC10755270</ArticleId><ArticleId IdType="pubmed">38163192</ArticleId></ArticleIdList></Reference><Reference><Citation>Barasheed O, Rashid H, Alfelali M, Tashani M, Azeem M, Bokhary H, et al. Viral respiratory infections among Hajj pilgrims in 2013. Virol Sin. 2014;29:364–371. doi: 10.1007/s12250-014-3507-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-014-3507-x</ArticleId><ArticleId IdType="pmc">PMC7090649</ArticleId><ArticleId IdType="pubmed">25413828</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkouiten S, Charrel R, Belhouchat K, Drali T, Nougairede A, Salez N, et al. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014;20:1821–1827. doi: 10.3201/eid2011.140600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2011.140600</ArticleId><ArticleId IdType="pmc">PMC4214309</ArticleId><ArticleId IdType="pubmed">25341199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashshi A, Azhar E, Johargy A, Asghar A, Momenah A, Turkestani A, et al. Demographic distribution and transmission potential of influenza A and 2009 pandemic influenza A H1N1 in pilgrims. J Infect Dev Ctries. 2014;8:1169–1175. doi: 10.3855/jidc.4204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.4204</ArticleId><ArticleId IdType="pubmed">25212081</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashem AM, Al-Subhi TL, Badroon NA, Hassan AM, Bajrai LHM, Banassir TM, et al. MERS-CoV, influenza and other respiratory viruses among symptomatic pilgrims during 2014 Hajj season. J Med Virol. 2019;91:911–917. doi: 10.1002/jmv.25424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25424</ArticleId><ArticleId IdType="pmc">PMC7166944</ArticleId><ArticleId IdType="pubmed">30729547</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Kafrawy SA, Alsayed SM, Alandijany TA, Bajrai LH, Faizo AA, Al-Sharif HA, et al. High genetic diversity of human rhinovirus among pilgrims with acute respiratory tract infections during the 2019 Hajj pilgrimage season. Int J Infect Dis. 2022;121:130–137. doi: 10.1016/j.ijid.2022.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.05.027</ArticleId><ArticleId IdType="pubmed">35577249</ArticleId></ArticleIdList></Reference><Reference><Citation>Alahmari AA, Khan AA, Alamri FA, Almuzaini YS, Alradini FA, Almohamadi E, et al. Hajj 2021: role of mitigation measures for health security. J Infect Public Health. 2022;15:1350–1354. doi: 10.1016/j.jiph.2022.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.09.006</ArticleId><ArticleId IdType="pubmed">36184475</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokhdar H, Khan A, Asiri S, Motair W, Assiri A, Alabdulaali M. COVID-19 mitigation plans during Hajj 2020: a success story of zero cases. Health Secur. 2021;19:133–139. doi: 10.1089/hs.2020.0144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hs.2020.0144</ArticleId><ArticleId IdType="pmc">PMC8060722</ArticleId><ArticleId IdType="pubmed">33264063</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumla A, Azhar EI, Alqahtani S, Shafi S, Memish ZA. COVID-19 and the scaled-down 2020 Hajj Pilgrimage-Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns. Int J Infect Dis. 2020;99:34–36. doi: 10.1016/j.ijid.2020.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.08.006</ArticleId><ArticleId IdType="pmc">PMC7409790</ArticleId><ArticleId IdType="pubmed">32771631</ArticleId></ArticleIdList></Reference><Reference><Citation>General Authority for Statistics. Hajj Statistics, https://www.stats.gov.sa/sites/default/files/HAJ%20ANN2021E_kp.pdf; 2021 [accessed 06 November 2022].</Citation></Reference><Reference><Citation>General Authority for Statistics. Hajj Report, https://www.stats.gov.sa/sites/default/files/file_manger/Hajj%20Report%201443H.pdf; 2022 [accessed 04 November 2022].</Citation></Reference><Reference><Citation>Alandijany TA, Faizo AA, Azhar EI. Coronavirus disease of 2019 (COVID-19) in the Gulf Cooperation Council (GCC) countries: current status and management practices. J Infect Public Health. 2020;13:839–842. doi: 10.1016/j.jiph.2020.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.05.020</ArticleId><ArticleId IdType="pmc">PMC7256540</ArticleId><ArticleId IdType="pubmed">32507401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahim SH, Memish ZA. Saudi Arabia's drastic measures to curb the COVID-19 outbreak: temporary suspension of the Umrah pilgrimage. J Travel Med. 2020;27:taaa029. doi: 10.1093/jtm/taaa029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taaa029</ArticleId><ArticleId IdType="pmc">PMC7107544</ArticleId><ArticleId IdType="pubmed">32109274</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed WA, Dada A, Alshukairi AN, Sohrab SS, Faizo AA, Tolah AM, et al. Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia. J King Saud Univ Sci. 2021;33 doi: 10.1016/j.jksus.2021.101366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jksus.2021.101366</ArticleId><ArticleId IdType="pmc">PMC7881290</ArticleId><ArticleId IdType="pubmed">33613011</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsi SH, Alandijany TA, Radwi M, Farsi A, Bahaaziq W, Abushoshah I, et al. Prevalence of COVID-19 antibodies among operating room and critical care staff at a tertiary teaching hospital: a cross-sectional study. Saudi Med J. 2021;42:742–749. doi: 10.15537/smj.2021.42.7.20210348.</Citation><ArticleIdList><ArticleId IdType="doi">10.15537/smj.2021.42.7.20210348</ArticleId><ArticleId IdType="pmc">PMC9195533</ArticleId><ArticleId IdType="pubmed">34187918</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshukairi AN, Al-Omari A, Al-Tawfiq JA, El-Kafrawy SA, El-Daly MM, Hassan AM, et al. Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation. J Infect Public Health. 2022;15:628–630. doi: 10.1016/j.jiph.2022.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.04.011</ArticleId><ArticleId IdType="pmc">PMC9047479</ArticleId><ArticleId IdType="pubmed">35576779</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan N. Metabolic disorders, COVID-19 and vaccine-breakthrough infections. Nat Rev Endocrinol. 2022;18:75–76. doi: 10.1038/s41574-021-00608-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00608-9</ArticleId><ArticleId IdType="pmc">PMC8647056</ArticleId><ArticleId IdType="pubmed">34873287</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshukairi AN, Al-Omari A, Albeity A, Alandijany TA, Hassan AM, El-Kafrawy SA, et al. COVID-19 breakthrough infections in rheumatic diseases patients after vaccination. J Infect Public Health. 2022;15:685–688. doi: 10.1016/j.jiph.2022.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.05.005</ArticleId><ArticleId IdType="pmc">PMC9098803</ArticleId><ArticleId IdType="pubmed">35623243</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe PG, Kang CK, Suh HJ, Jung J, Song K-H, Bang JH, et al. Waning antibody responses in asymptomatic and symptomatic SARS-CoV-2 infection. Emerg Infect Dis. 2021;27:327–329. doi: 10.3201/eid2701.203515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2701.203515</ArticleId><ArticleId IdType="pmc">PMC7774548</ArticleId><ArticleId IdType="pubmed">33050983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko J-H, Joo E-J, Park S-J, Baek JY, Kim WD, Jee J, et al. Neutralizing antibody production in asymptomatic and mild COVID-19 patients, in comparison with pneumonic COVID-19 patients. J Clin Med. 2020;9:2268. doi: 10.3390/jcm9072268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9072268</ArticleId><ArticleId IdType="pmc">PMC7408950</ArticleId><ArticleId IdType="pubmed">32708872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashim S, Ayub ZN, Mohamed Z, Hasan H, Harun A, Ismail N, et al. The prevalence and preventive measures of the respiratory illness among Malaysian pilgrims in 2013 Hajj season. J Travel Med. 2016;23:tav019. doi: 10.1093/jtm/tav019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/tav019</ArticleId><ArticleId IdType="pmc">PMC7107508</ArticleId><ArticleId IdType="pubmed">26858268</ArticleId></ArticleIdList></Reference><Reference><Citation>Faizo AA, Qashqari FS, El-Kafrawy SA, Barasheed O, Almashjary MN, Alfelali M, et al. A potential association between obesity and reduced effectiveness of COVID-19 vaccine-induced neutralizing humoral immunity. J Med Virol. 2023;95:e28130. doi: 10.1002/jmv.28130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28130</ArticleId><ArticleId IdType="pmc">PMC9539352</ArticleId><ArticleId IdType="pubmed">36068377</ArticleId></ArticleIdList></Reference><Reference><Citation>Binnicker MJ. Can testing predict SARS-CoV-2 infectivity? The potential for certain methods to be surrogates for replication-competent virus. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.00469-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00469-21</ArticleId><ArticleId IdType="pmc">PMC8525553</ArticleId><ArticleId IdType="pubmed">34346713</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>